Results 221 to 230 of about 249,115 (256)
Some of the next articles are maybe not open access.
The economics of mild cognitive impairment
Alzheimer's & Dementia, 2012Individuals with amnestic mild cognitive impairment (MCI) are at elevated risk of developing Alzheimer's disease (AD). Although the economic burden of AD itself is well recognized, little is known about the direct and indirect costs associated with MCI before the onset of AD.
Pei-Jung, Lin, Peter J, Neumann
openaire +2 more sources
Neuropathology of mild cognitive impairment
Neuropathology, 2007We aim to investigate the pathological background of mild cognitive impairment (MCI). The most recent 545 cases from the Brain Bank for Aging Research (BBAR) were studied, with a mean age of 80.7 years and male : female ratio of 324 : 221. Cases with clinical dementia rating scale (CDR) 0.5 were retrieved as the best substitute of MCI.
Yuko, Saito, Shigeo, Murayama
openaire +2 more sources
Hypertension and Mild Cognitive Impairment
Current Hypertension Reports, 2012The brain is an early target for organ damage due to high blood pressure. Hypertension is the major modifiable risk factor for stroke and small vessel disease. It has been suggested that cerebral microvascular disease contributes to vascular cognitive impairment.
Cristina, Sierra +3 more
openaire +2 more sources
Mild cognitive impairment: Believe it or not?
International Review of Psychiatry, 2008Mild cognitive impairment (MCI) was previously defined as a transitional state that can precede dementia, but the condition and the rates of conversion remain controversial. MCI is now the focus of natural history studies, along with Alzheimer's disease (AD) prevention.
Ricardo F, Allegri +3 more
openaire +2 more sources
Discussing Mild Cognitive Impairment
Focus, 2021Dr. Purganan reports that her spouse has served on an advisory board for Dova Pharmaceuticals and Targeted Oncology, has served as a speaker for the Chronic Liver Disease Foundation/Focus Medical Communications, has received research funding from Arrowhead Pharmaceuticals, and has received sponsored travel for research support from Arrowhead ...
openaire +2 more sources
Treatment of Mild Cognitive Impairment
Current Treatment Options in Neurology, 2015It is increasingly evident that early identification of cognitive impairment in older adults presents opportunities for interventions that aim to mitigate the impact of cognitive symptoms on daily function and that attempt to delay (or ultimately prevent) progression from mild cognitive impairment (MCI) to dementia.
openaire +2 more sources
Frontotemporal mild cognitive impairment
Journal of Alzheimer's Disease, 2004Mild Cognitive Impairment appears to be a heterogeneous clinical entity comprising patients in the initial phases of distinct neurological disorders. Since frontotemporal dementia (FTD) is a relatively common neurodegenerative disease with an insidious onset, it might be possible to detect the patients in the initial phases of the disorder, before ...
Alexandre, de Mendonça +3 more
openaire +2 more sources
Leukoaraiosis with mild cognitive impairment
Neurological Research, 2015As the ageing population continues to increase, the prevalence of age-related cognitive impairment has been on the rise. Mild cognitive impairment (MCI) is now widely recognised as the early stage of dementia. Mild cognitive impairment is closely associated with cerebral white matter lesions (WMLs), specifically in the case of leukoaraiosis (LA).
Mi, Te +4 more
openaire +2 more sources
Huisarts en wetenschap, 2012
Mild cognitive impairment (MCI), a heterogeneous disorder, is frequently diagnosed by geriatricians and neurologists and is a hot topic in research. MCI refers to cognitive impairment that is worse than would be expected on the basis of age but which does not meet the criteria for dementia. The diagnosis is based on the patient history and an interview
Verwoerd, J. H., Mattace-Raso, F. U.S.
openaire +3 more sources
Mild cognitive impairment (MCI), a heterogeneous disorder, is frequently diagnosed by geriatricians and neurologists and is a hot topic in research. MCI refers to cognitive impairment that is worse than would be expected on the basis of age but which does not meet the criteria for dementia. The diagnosis is based on the patient history and an interview
Verwoerd, J. H., Mattace-Raso, F. U.S.
openaire +3 more sources
Update on mild cognitive impairment
Current Neurology and Neuroscience Reports, 2003Mild cognitive impairment (MCI) refers to persons whose memory or other cognitive abilities are not normal, but who do not have clinically diagnosed dementia. MCI has received considerable attention in the medical literature over the past few years.
openaire +2 more sources